Medicumnova - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 185,555 | 212,329 | 188,265 | 241,472 | 263,178 | 259,597 | 253,475 | 249,571 |
| Profit before tax | -4,196 | 3,994 | 27,639 | 38,446 | 31,248 | 27,768 | 12,939 | 10,664 |
| Net profit | -4,196 | 3,789 | 26,359 | 36,714 | 29,842 | 26,484 | 12,347 | 10,113 |
| Equity | -33,716 | -29,927 | -3,567 | 33,147 | 52,989 | 55,474 | 49,821 | 43,933 |
| Liabilities | 86,593 | 88,871 | 94,331 | 59,204 | 42,790 | 30,594 | 25,361 | 27,729 |
| Non-current assets | 2,547 | 1,329 | 2,342 | 1,862 | 1,964 | 886 | 403 | 7 |
| Current assets | 50,165 | 57,557 | 88,365 | 90,430 | 93,761 | 85,122 | 74,732 | 71,589 |
| Total assets | 52,712 | 58,886 | 90,707 | 92,292 | 95,725 | 86,008 | 75,135 | 71,596 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 68,022 | 67,607 | 65,388 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.0% | +14.4% | -11.3% | +28.3% | +9.0% | -1.4% | -2.4% | -1.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -8.0% | 6.4% | 29.1% | 39.8% | 31.2% | 30.8% | 16.4% | 14.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | 110.8% | 56.3% | 47.7% | 24.8% | 23.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2.3% | 1.8% | 14.0% | 15.2% | 11.3% | 10.2% | 4.9% | 4.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -2.3% | 1.9% | 14.7% | 15.9% | 11.9% | 10.7% | 5.1% | 4.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 1.8 | 0.8 | 0.6 | 0.5 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 46,389 | 53,082 | 47,066 | 80,491 | 87,726 | 86,532 | 84,492 | 83,190 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicumnova - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-08-28 | 2025-08-29 | 1.40 |
| 2025-08-19 | 2025-08-24 | 1.40 |
| 2025-07-24 | 2025-08-13 | 1.40 |
| 2025-05-16 | 2025-05-18 | 1292.49 |
| 2024-08-19 | 2024-09-11 | 1.67 |
| 2024-07-24 | 2024-08-12 | 1.67 |
| 2024-04-16 | 2024-04-18 | 1392.98 |
| 2022-05-17 | 2022-06-13 | 0.33 |
| 2022-04-25 | 2022-05-09 | 0.33 |
| 2022-02-17 | 2022-03-09 | 0.33 |
| 2022-01-27 | 2022-02-14 | 0.33 |
Medicumnova - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 1.21 |
| 2026-01-30 | 2026-02-16 | 1.21 |
| 2026-01-29 | 2026-01-29 | 1.52 |
| 2026-01-01 | 2026-01-22 | 1.52 |
| 2025-11-28 | 2025-12-30 | 0.55 |
| 2025-11-14 | 2025-11-25 | 0.55 |
| 2025-04-18 | 2025-04-24 | 0.08 |
| 2025-04-16 | 2025-04-17 | 0.45 |
| 2025-04-11 | 2025-04-15 | 0.13 |
| 2025-04-02 | 2025-04-10 | 0.08 |
| 2025-03-28 | 2025-04-01 | 0.09 |
| 2025-03-15 | 2025-03-27 | 0.05 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicumnova, UAB (code 300037749) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €249.6K and net profit of €10.1K, with a profit margin of about 4%. Revenue was slightly lower than in 2024, when it reached €253.5K, and also below the 2023 level of €259.6K, indicating a gradual three-year softening in turnover. Net profit followed the same direction, decreasing from €26.5K in 2023 to €12.3K in 2024 and €10.1K in 2025. At year-end 2025, total assets stood at €71.6K, equity at €43.9K and liabilities at €27.7K. The equity ratio was 61.4%, debt-to-equity was 0.63, and asset turnover was 3.49x. Return on equity was 23.0% and return on assets 14.1%. Revenue per employee was €83.2K, while profit per employee was €3.4K, pointing to solid operating productivity despite the lower earnings level.